Tubridy N - Search Results

1

Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features.

Tubridy N, Coles AJ, Molyneux P, Compston DA, Barkhof F, Thompson AJ, McDonald WI, Miller DH. Tubridy N, et al. Brain. 1998 Feb;121 ( Pt 2):225-31. doi: 10.1093/brain/121.2.225. Brain. 1998. PMID: 9549501 Clinical Trial.

2

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

Barkhof F, Filippi M, van Waesberghe JH, Molyneux P, Rovaris M, Lycklama à Nijeholt G, Tubridy N, Miller DH, Yousry TA, Radue EW, Adèr HJ. Barkhof F, et al. Among authors: tubridy n. Neurology. 1997 Dec;49(6):1682-8. doi: 10.1212/wnl.49.6.1682. Neurology. 1997. PMID: 9409366

3

Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups.

Tubridy N, Ader HJ, Barkhof F, Thompson AJ, Miller DH. Tubridy N, et al. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):50-5. doi: 10.1136/jnnp.64.1.50. J Neurol Neurosurg Psychiatry. 1998. PMID: 9436727 Free PMC article.

4

Optimisation of unenhanced MRI for detection of lesions in multiple sclerosis: a comparison of five pulse sequences with variable slice thickness.

Tubridy N, Barker GJ, MacManus DG, Moseley IF, Miller DH. Tubridy N, et al. Neuroradiology. 1998 May;40(5):293-7. doi: 10.1007/s002340050587. Neuroradiology. 1998. PMID: 9638669

5

The effect of section thickness on MR lesion detection and quantification in multiple sclerosis.

Molyneux PD, Tubridy N, Parker GJ, Barker GJ, MacManus DG, Tofts PS, Moseley IF, Miller DH. Molyneux PD, et al. Among authors: tubridy n. AJNR Am J Neuroradiol. 1998 Oct;19(9):1715-20. AJNR Am J Neuroradiol. 1998. PMID: 9802495 Free PMC article. Clinical Trial.

6

Three-dimensional fast fluid attenuated inversion recovery (3D fast FLAIR): a new MRI sequence which increases the detectable cerebral lesion load in multiple sclerosis.

Tubridy N, Barker GJ, Macmanus DG, Moseley IF, Miller DH. Tubridy N, et al. Br J Radiol. 1998 Aug;71(848):840-5. doi: 10.1259/bjr.71.848.9828796. Br J Radiol. 1998. PMID: 9828796 Clinical Trial.

7

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

Tubridy N, Behan PO, Capildeo R, Chaudhuri A, Forbes R, Hawkins CP, Hughes RA, Palace J, Sharrack B, Swingler R, Young C, Moseley IF, MacManus DG, Donoghue S, Miller DH. Tubridy N, et al. Neurology. 1999 Aug 11;53(3):466-72. doi: 10.1212/wnl.53.3.466. Neurology. 1999. PMID: 10449105 Clinical Trial.

8

Multiple sclerosis: interobserver agreement in reporting active lesions on serial brain MRI using conventional spin echo, fast spin echo, fast fluid-attenuated inversion recovery and post-contrast T1-weighted images.

Rovaris M, Barkhof F, Bastianello S, Gasperini C, Tubridy N, Yousry TA, Sormani MP, Viti B, Miller DH, Filippi M. Rovaris M, et al. Among authors: tubridy n. J Neurol. 1999 Oct;246(10):920-5. doi: 10.1007/s004150050483. J Neurol. 1999. PMID: 10552239

9

Long term use of desmopressin for urinary symptoms in multiple sclerosis.

Tubridy N, Addison R, Schon F. Tubridy N, et al. Mult Scler. 1999 Dec;5(6):416-7. doi: 10.1177/135245859900500i608. Mult Scler. 1999. PMID: 10618698

10

The sensitivity of thin-slice fast spin echo, fast FLAIR and gadolinium-enhanced T1-weighted MRI sequences in detecting new lesion activity in multiple sclerosis.

Tubridy N, Molyneux PD, Moseley IF, Miller DH. Tubridy N, et al. J Neurol. 1999 Dec;246(12):1181-5. doi: 10.1007/s004150050540. J Neurol. 1999. PMID: 10653313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters